Agonist stimulation of Group III metabotropic glutamate receptors (mGluRs) induces an inhibition of neurotransmitter release from neurons. The Group III mGluRs are pharmacologically defined by activation with the glutamate analog L-amino-4-phosphonobutyric acid (L-AP4). The affinities of these receptors for L-AP4 and glutamate vary over approximately a 1500-fold concentration range. The goal of this study was to elucidate the molecular basis for this dispersion of agonist affinities for the Group III receptors mGluR4, mGluR6, and mGluR7. [ binding to mGluR6. Homology models of mGluR4 and mGluR7 were employed to predict amino acids that may affect ligand affinity. Mutations were made in mGluR7 to convert selected residues into the equivalent amino acids present in the high affinity mGluR4 receptor. The mGluR7 N74K mutation caused a 12-fold increase in affinity in a functional assay, while the N74K mutation in combination with mutations in residues 258 -262, which lie outside the binding pocket, caused a 112-fold increase in affinity compared to unmutated mGluR7. Our results demonstrate that the binding site residues at position lysine 74 in mGluR4, glutamine 58 in mGluR6, and asparagine 74 in mGluR7 are key determinants of agonist affinity and that additional residues situated outside of the binding pocket, including those present in the extreme amino terminus, also contribute to agonist affinity and the pharmacological profiles of the Group III mGluRs.
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Introduction
The Group III metabotropic glutamate receptors (mGluRs; mGluR4, 6, 7 and 8) share 70-74% amino acid identity and are selectively activated by the synthetic agonist Lamino-4-phosphonobutyric acid (L-AP4), and the endogenous amino acid L-serine-Ophosphate (L-SOP; Fig. 1 ). The mGluR4, mGluR7, and mGluR8 receptor subtypes are expressed primarily on nerve terminals where they act to inhibit neurotransmitter release in the central and peripheral nervous systems (Macek et al., 1996; Pekhletski et al., 1996; Shigemoto et al., 1996; Lafon-Cazal et al., 1999) . mGluR6 expression is restricted to retinal bipolar cells where it acts postsynaptically to regulate visual responses (Nomura et al., 1994) . Animal models have suggested mGluR4 as a potential drug target for the treatment of absence epilepsy (Snead et al., 2000) , neurodegenerative disorders associated with over-activation of glutamate-gated ion channels (Bruno et al., 2000) and Parkinson's disease (Marino et al., 2003) , while mGluR7 may be a potential target for the development of novel antidepressants (Cryan et al., 2003) .
Agonists at mGluRs bind to a site localized within the Venus flytrap domain of the extracellular region and induce a conformational change which results in the closure of the flytrap and propagation of the signal through the transmembrane domain (Bessis et al., 2002; Jingami et al., 2003) . Although the Group III receptors have high sequence homology, their affinities for L-AP4, L-SOP, and L-glutamate span a wide concentration range encompassing several orders of magnitude. This large dispersion of affinities for endogenous ligands suggests that the Group III receptors have evolved to operate over a wide range of intensities of synaptic activity. This article has not been copyedited and formatted. The final version may differ from this version.
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Biochemical assays measuring receptor activation together with radioligand binding assays using [ 3 H]L-AP4 have shown that mGluR4 and mGluR8 have similar high affinity for L-AP4 (EC 50 = 0.4 -1 µM, IC 50 = 0.4 -0.8 µM; Han and Hampson, 1999; Hampson et al., 1999; Peltekova et al., 2000; Schoepp et al., 1999) . As expected based on the reported low affinity of L-AP4 for mGluR7 in functional assays (EC 50 = 160 -800 µM, Okamoto et al., 1994; Saugstad et al., 1994; Corti et al., 1998) , no specific binding of [ 3 H]L-AP4 was detected in cells expressing mGluR7 (Naples and Hampson, 2001) .
Surprisingly however, despite reports indicating that mGluR6 has a pharmacological profile similar to mGluR4 and mGluR8 in functional assays, (i.e. high affinity for L-AP4, EC 50 = 0.6 -0.9 µM; Nakajima et al., 1993; Ahmadian et al., 1997) , no specific binding of [
H]L-AP4 was detected human embryonic kidney (HEK) 29cells transfected with
either rat or human mGluR6 (Naples and Hampson et al., 2001 ).
Previous studies have determined that the selectivity of L-AP4 and L-SOP for mGluR4 is conferred by several positively charged amino acids within the ligand binding pocket that interact with the negatively charged phosphonate moiety of these compounds (Bertrand et al., 2002; Rosemond et al., 2002; Macchiarulo et al., 2003) . In the present study, the molecular basis for the differential affinities and agonist binding properties of mGluR4, mGluR6, and mGluR7 was investigated. Our results demonstrate that a specific subset of residues located within and just outside of the binding pocket is and mGluR7 were produced within the mGluR7-c-myc background (pcDNA3.1/mycHis). Restriction enzyme sites at equivalent positions in the cDNAs of mGluR4 and mGluR7 were used to construct the chimeric receptors. The 4/7A chimera (mGluR4 1-315 /mGluR7 317-915 ) used the BamH1 site, the 4/7B chimera (mGluR4 1-286 /mGluR7 used the NruI site, the 4/7C chimera (mGluR4 1-221 /mGluR7 222-915 ) used the SalI site and the 4/7D chimera (mGluR4 1-110 /mGluR7 109-915 ) used the XhoI restriction enzyme site. All of the single and multiple point mutations in mGluR7 were made on the modified CaSRmGluR7 construct described above. All chimeras and mutants were sequenced prior to analysis.
Cell Culture and transfections. HEK-293-TSA-201 cells were cultured in minimal essential medium supplemented with 6% fetal bovine serum, 2mM glutamine and penicillin-streptomycin antibiotics (Invitrogen, Carlsbad, CA, USA). For radioligand binding assays, transient transfections of HEK cells were conducted using a calcium phosphate precipitation protocol as described previously (Han and Hampson, 1999 Radioligand Binding. Membranes were harvested 48 hours post-transfection and prepared as previously described (Naples and Hampson, 2001; Rosemond et al., 2002) .
Frozen membranes were thawed and homogenized using a Polytron. 125 µg of membrane protein was used for all binding assays in a final volume of 250 µl. All assays were performed on ice using 30 nM [ Functional assay for mGluRs. Responses to L-AP4 were measured in HEK cells loaded with the calcium-sensitive dye Fluo-4 in a fluorescence-based assay as described previously (Kuang et al., 2003; Yao et al., 2003 Immunoblotting. Electrophoresis samples containing 100 mM dithiothreitol were incubated at 37 o C for 15 minutes prior to gel electrophoresis. The procedure for immunoblotting was conducted as described previously (Pickering et al., 1995) .
Molecular Modeling.
A homology model of the closed form of the extracellular domain of human mGluR7 was generated using the X-ray crystal structure of the extracellular domain of rat mGluR1 as a template (Kunishima et al., 2000, PDB coordinates, 1EWK.pdb). The sequence alignment between the rat mGluR1 and human mGluR7 sequences was adopted from the multiple alignment of the eight mGluRs (Fig. 2). The alignment was checked to avoid gap insertions in the conserved secondary structural motifs. MODELER 6 ( Sali and Blundell, 1993) server (Luthy et. al., 1992) were used to assess the integrity of the model. The best initial model was subjected to further refinement using energy minimization with AMBER 7.0 (Case et. al., 2001 ). The force field parameters for the ligands were developed with the aid of the antechamber module in AMBER. The coordinates for the zwitterionic forms of glutamate and L-AP4 were generated in an extended conformation using the Xleap module in AMBER 7.0. The ionization state of the phosphate group of L-AP4 was PO 3 -2 .
The mGluR7 homology model was first energy minimized with glutamate docked in the same orientation as in the mGluR1 crystal structure. The complex was solvated in a TIP3P water box (Jorgensen et. al., 1983) so that the box boundaries were at least 10 angstroms away from any protein atom. A water molecule in the crystal structure of mGluR1 between the bound glutamate and arginine 78 was retained in the mGluR7 model because this amino acid is conserved in all mGluRs. Additional water molecules were placed in the binding pocket by solvation using AMBER. Although the placement of the water molecules in the binding pocket causes a negative and thus unfavorable change in entropy, this procedure optimizes the interactions between the ligand and the receptor. Counter ions (Cl -) were added to neutralize the system. The coordinates for the solvated complex were then energy minimized in AMBER 7.0 using the Cornell force field. A dielectric multiplicative constant of 1.0 was used to calculate the electrostatic interactions and a cut off of 12 angstrom was used for nonbonding interactions. The final energy minimization was carried out by restraining the protein backbone and then reducing the constraints gradually to zero. Subsequently, the model was minimized for 5000 steps without constraints. The bound glutamate was replaced by L-AP4 and the mGluR7-L-AP4 complex was energy minimized as described above.
Results
Pharmacological profiles of mGluR4, mGluR6 and mGluR7
In heterologous expression systems the Group III mGluRs are coupled to the inhibition of adenylyl cyclase. To switch the signal transduction system to the stimulation of phosphoinositide turnover and release of intracellular calcium, the receptor cDNAs were transiently co-transfected with the cDNA coding for the promiscuous Gα15
This article has not been copyedited and formatted. The final version may differ from this version.
G-protein subunit to artificially couple the receptor to the phospholipase C pathway (Gomeza et al., 1996) . L-AP4-induced responses were monitored by measuring the release of intracellular calcium in HEK cells loaded with the calcium-sensitive dye, Fluo-4. The EC 50 values for L-AP4 for mGluR4 and mGluR6 were 0.29 ± 0.03 and 1.97 ± 0.59 µM respectively (Fig. 3) . In contrast, no responses were observed in cells coexpressing either rat or human mGluR7 and Gα15 (or the chimeric G-protein Gqi9) with concentrations of L-AP4 up to 500 µM. However, responses were consistently obtained in HEK cells co-transfected with Gα15 and a construct in which the first the first 44 amino acids of the human mGluR7 receptor were replaced with the first 27 amino acids of the human CaSR; the EC 50 value for L-AP4 was 429 ± 134 µM.
Analysis of chimeras of mGluR4 and mGluR6
We previously reported that in HEK cells expressing mGluR4, high levels of (Fig. 3) . Membranes prepared from cells expressing the mGluR4/6 chimeras and the mGluR6 wild-type receptor were probed on immunoblots with a C-terminal anti-mGluR6 antibody; the mGluR6 receptor was highly expressed while the chimeras were expressed at lower levels (Fig. 4) .
This article has not been copyedited and formatted. The final version may differ from this version. The mGluR4/6A chimera encompassed the complete extracellular domain of mGluR4 (amino acids 1-586) spliced to the transmembrane and C-terminal regions of mGluR6 (amino acids 579-871). Autocompetition radioligand binding experiments with labeled and unlabeled L-AP4 showed that the mGluR4/6A chimera had an affinity for L-AP4 that was similar that of wild-type mGluR4 (4/6A IC 50 = 0.43 ± 0.04 µM; mGluR4 IC 50 = 0.35 ± 0.10 µM, Fig. 3 ). However, in the functional assay the 4/6A chimera was not activated by L-AP4 at concentrations of up to 500 µM. The lack of activity with the m4/6A chimera could have been caused by the two amino acid change at the junction of the extracellular domain and the transmembrane domain region in the construction of this chimera. However, it should be noted that other non-functional chimeras have also been observed in other family C receptors (e.g. mGluR2/mGluR1, Takahashi et al., 1993;  mGluR1/DmGluRA, Paramentier et al., 1998; GABA B R1/mGluR1, Malitschek et al., 1999; mGluR1/4, Maj et al., 2003) .
The mGluR4/6B chimera contained the first 110 amino acids of mGluR4 spliced to amino acids 95-871 of mGluR6, the mGluR4/6C chimera contains the first 78 amino acids of mGluR4 spliced to amino acids 63-871 of mGluR6, and the mGluR4/6D chimera contains the first 50 amino acids of mGluR4 spliced to amino acids 35-871 of mGluR6.
All of these chimeras displayed affinities for L-AP4 similar to the wild-type mGluR4 receptor in the autocompetition binding assay and in the functional assay (Fig. 3 ). These findings indicate that the region of the mGluR6 receptor responsible for the lack of The affinity of L-AP4 for activation of mGluR6 is influenced by amino acids within the ligand binding pocket. To explore the ligand binding pocket of mGluR6, amino acids that establish bonds with agonists in the binding pocket were mutated to alanine residues. We previously generated a structural model of mGluR4 with L-SOP docked into the binding pocket (Rosemond et al., 2002) based on the crystal structure of mGluR1 (Kunishima et al., 2000; Tsuchiya et al., 2002) . Two amino acids within the binding pockets differ between mGluR4 and mGluR6; lysine 74 and glycine 158 in mGluR4 correspond to glutamine 58 and alanine 159 in mGluR6 (see Fig. 2 ). The mGluR6 Q58K/A159G double mutant displayed a 7-fold higher affinity for L-AP4 in the functional assay (EC 50 = 0.27 ± 0.14 µM) compared to the wild-type mGluR6 receptor with an affinity that was similar to wild-type mGluR4. Surprizingly however, the Q58K/A159G mutant showed no specific [ 
Analysis of mGluR7
To identify regions of the extracellular domain of mGluR7 receptor responsible for the low affinity of this receptor for agonists, four chimeras of mGluR4 and mGluR7
were studied (Fig. 6) . The mGluR4/7A chimera included the first 315 amino acids of rat mGluR4 spliced to amino acids 317-915 of mGluR7. This chimera displayed a similar affinity for A homology model of mGluR7 was generated to facilitate further analysis of L-AP4 interactions at this receptor. The degree of amino acid sequence identity between mGluR7 and the template (mGluR1) within the region modeled was 41%. The model indicated that the ligand binding pocket of mGluR7 differs from mGluR4 by two residues; asparagine 74 in mGluR7 is a lysine in mGluR4, and aspartate 289 in mGluR7 is a glutamate in mGluR4 (Figs. 2 and 5) . Surprisingly, conservatively mutating aspartate 289 in mGluR7 to glutamate caused a complete loss of detectable protein on immunoblots; however, this mutant was detected when the cells were incubated with the proteosome inhibitor MG-132 prior to analysis on SDS-PAGE (Fig. 4C) . In contrast to D289E, converting asparagine 74 in mGluR7 to lysine increased the affinity for L-AP4
by 12-fold (EC 50 = 35.6 ± 14 µM, receptors. This difference is readily apparent when the carbon backbone derived from the mGluR7 model is overlaid onto the structural model of mGluR4 where it can be seen that this stretch of residues forms a small loop in mGluR7 that is not present in the other Group III receptors (Fig. 7) . This five amino acid segment in mGluR7 is represented by only three amino acids in the other Group III receptors. We hypothesized that although this section of the polypeptide lies just outside of the binding pocket, it may influence ligand affinity. Therefore, the two extra residues in mGluR7 were deleted (glutamine 258 and glutamate 259, termed the QE deletion mutant) and then further mutants were produced that combined the QE deletion mutant with additional mutations in mGluR7 designed to mimic mGluR4. These included a triple mutant (QE deletion + K261E), a tetra-mutant (QE deletion + K261E and D262P), a penta-mutant (QE deletion + K261E +
D262P + N74K) and a hexa-mutant (QE deletion + K261E + D262P + N74K + D289E).
The mutants were analyzed in the fluorescence-based functional assay and the results are summarized in Table 1 . All of the mutants in this series displayed affinities that were higher than the unmutated mGluR7 except for the QE deletion mutant where no responses were seen. The highest affinity mutant was the penta-mutant (EC 50 = 3.8 ± 0.8 µM) which included the deletion of two residues (Q258 and E259) and the replacement of two residues (K261E + D262P) in the loop region and replacement of one residue in the binding pocket (N74K). The hexa-mutant, which included the five amino acids in the penta-mutant plus the second binding pocket mutation D289E, showed a lower affinity (EC 50 = 9. 3 ± 0.22 µM) compared to the penta-mutant.
Discussion
This article has not been copyedited and formatted. The final version may differ from this version. Glutamate and GABA mediated excitatory and inhibitory synaptic transmission are tightly regulated processes. In the central nervous system, Group III mGluRs are present on both glutamatergic neurons and GABAergic interneurons (Shigemoto et al., 1996; Bradley et al., 1999; Corti et al., 2002) , the latter of which are thought to be activated by glutamate "spillover" from nearby glutamatergic terminals (Mitchell and Silver, 2000; Semyanov and Kullmann, 2000) . The precise amount of glutamate and GABA released is determined in part by the presence of the different subtypes of presynaptic mGluRs. Thus the affinity of a presynaptic mGluR for glutamate is a critical factor in regulating synaptic neurotransmitter levels.
We previously proposed that the inhibitory properties of mGluR4 on neurotransmitter release are an important parameter in maintaining the appropriate level of neuronal firing during synaptic transmission (Pekhletski et al., 1996) . High affinity receptors such as mGluR4 and mGluR8 would be activated at low levels of synaptic activity whereas high frequency neuronal firing would be required to activate the low affinity mGluR7 receptor (Sansig et al., 2001) . Results from more recent studies also indicate that some L-AP4 sensitive receptors are tonically activated by resting levels of extracellular glutamate (Xi et al., 2003; Acuna-Goycolea et al., 2004) .
The results from the present study provide an explanation for the molecular basis of the differential agonist affinities of the Group III mGluRs. A side by side comparison of mGluR4, mGluR6, and mGluR7 expressed in HEK cells indicated that in the functional assay, wild-type mGluR4 and mGluR6 showed robust activity while no receptor activation was observed with either rat or human mGluR7. The inability to detect responses to mGluR7 was likely not caused by a lack of cell surface expression This article has not been copyedited and formatted. The final version may differ from this version. Another possibility is that proper processing and cleavage of the signal peptide may be required for maintaining a high affinity conformation of the receptor, or alternatively, the extreme amino terminus of the mature receptor, excluding the putative cleaved signal peptide sequence may indirectly affect the precise 3-dimensional architecture of the binding pocket and therefore ligand affinity. We note that the importance of the first 30-50 residues in the Group III mGluRs is also reflected in the observation that replacement of this region in mGluR7 with amino acids of the CaSR was required for generating functional responses to mGluR7 in HEK cells. Taken together, these findings indicate that the extreme amino termini contribute to the tertiary structure and pharmacological properties the Group III mGluRs.
The molecular basis for the very low affinity of mGluR7 was first examined in a series of chimeras between mGluR4 and mGluR7. A pharmacological profile roughly similar to mGluR4 was seen in the mGluR4/7A chimera that contained the first 315 amino acids of mGluR4 ligated to the complementary downstream sequence of mGluR7.
The mGluR4/7B and mGluR4/7C chimeras had progressively smaller segments of mGluR4 and displayed affinities in the functional assay that were three and ten fold lower than mGluR4 respectively.
The mGluR4/7A chimera included the only two residues in the ligand binding contribution of these two residues to the affinity of L-AP4, we generated and characterized the mGluR7 mutants N74K and D289E. The N74K mutant displayed a 12-fold increase in affinity over wild-type mGluR7, while the D289E mutant was undetectable on immunoblots unless a proteosome inhibitor was present. This latter observation indicates that the D289E mutant was rapidly degraded.
The largest mutagenesis-induced shift to higher affinity in mGluR7 was seen in the penta-mutant where four residues comprising a small loop outside of the binding pocket and the binding pocket residue asparagine 74 were mutated to the equivalent amino acids in mGluR4. This loop region is situated on the top of lobe II just outside of the pocket containing the docked ligand and protrudes into the cavity formed by the two lobes of the Venus flytrap (Fig. 7) . The data suggest that this loop or "bump" in the polypeptide chain contributes to the lower agonist affinity of mGluR7. The residues in this region may perturb the binding pocket residues that make direct contact with the bound ligand such that they establish less favorable contacts with the ligand compared with the high affinity L-AP4 receptors. Alternatively, the protrusion of this loop into the cavity formed by the two lobes may hinder full closure of the lobes in the Venus flytrap domain. This scenario would be consistent with a previous proposal that ligand affinity depends in part on the propensity of the ligand to stabilize the closed conformation of the Venus flytrap (Parmentier et al., 2002) .
Our results also clearly demonstrate that a primary contributor to agonist affinity (i.e. a tyrosine in Group I receptors and an arginine in Group II receptors, Fig. 2 ). We suggest that the higher affinity of mGluR4 (and mGluR8 ) is mediated in part by an ion pair formed between lysine 74 in mGluR4 (and lysine 71 in mGluR8) and the phosphonate group of L-AP4 and L-SOP, and that the lower affinity of mGluR6 is caused by the replacement of the charged lysine with polar glutamine which likely establishes a lower energy hydrogen bond with the phosphonate group (Fig. 8) . In mGluR7, we
propose that a water molecule could link the oxygen atoms of the phosphonate group on L-AP4 and aspargine 74. In the homology model, the distance between these two oxygens is 4.3 angstroms which is sufficient to accommodate a water molecule as shown in Figure 8 . Although the longer length of the charged side chain of lysine 74 in this position in mGluR4 precludes the presence of a water molecule, this residue likely establishes a direct interaction with the ligand that may contribute to the higher agonist affinity of this receptor. We predict that the various residues occupying this position in the mGluRs would be good candidates for structure based drug design efforts seeking to optimize ligand selectivity and affinity.
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